2339 |
Autopsy Studies of TAVR - What Have We Learnt? |
Renu Virmani |
Apr. 20. 15 |
2338 |
[Special Lecture] Promoting Cardiovascular Health(2015-2020): A Fast Evolving Trend, Locally and Globally |
Valentin Fuster |
Apr. 20. 15 |
2337 |
More Than Twelve Months! |
Cheol Whan Lee |
Apr. 20. 15 |
2336 |
Theoretical Construct: Why BRS May Change the Landscape of Coronary Intervention? |
Patrick W. Serruys |
Apr. 20. 15 |
2335 |
Six Months Enough! |
David Joel Cohen |
Apr. 20. 15 |
2334 |
Bioresorbable Scaffolds in Complex Coronary Lesions |
Corrado Tamburino |
Apr. 20. 15 |
2333 |
Beyond IVUS: OCT, NIRS, and Beyond |
Akiko Maehara |
Apr. 20. 15 |
2332 |
Vulnerable Plaque Detection and Treatment: PROSPECT II and PROSPECT ABSORB |
Gregg W. Stone |
Apr. 20. 15 |
2331 |
IVUS Optimization of PCI and Future Directions: A 25-Year Perspective |
Gary S. Mintz |
Apr. 20. 15 |
2330 |
How to Treat? - Functionally Insignificant Vulnerable Plaque: STABLE and PREVENT |
Seung-Jung Park |
Apr. 20. 15 |